Does monthly self-management of vaginal ring pessaries reduce the rate of adverse events? A clinical audit [PDF]
Objective: To determine the rate of adverse events (AE) in women who self-manage their vaginal ring pessary on a monthly basis. We hypothesised that the AE rate would be lower compared to previously published traditional management protocols.
Kate H. Moore +4 more
doaj +2 more sources
Participant experiences with a multipurpose vaginal ring for HIV and pregnancy prevention during a phase 1 clinical trial: learning from users to improve acceptability [PDF]
IntroductionWith high concurrent global rates of HIV incidence and unintended pregnancy, there is a need to provide options beyond condoms to enable users to simultaneously prevent HIV acquisition and pregnancy.
Mary Kate Shapley-Quinn +11 more
doaj +2 more sources
Self-reported removal and expulsion of the dapivirine vaginal ring: qualitative reports from female ring users and their male partners in the Ring Study (IPM 027) [PDF]
Background/aims The dapivirine vaginal ring is a self-administered, women-initiated, discreet, long-acting HIV-1 prevention option for women. It was found to be safe and effective in healthy HIV-negative women who adhered to product use instructions, and
Cecilia Milford +6 more
doaj +2 more sources
Acceptability of an extended duration vaginal ring for HIV prevention and interest in a multi-purpose ring. [PDF]
Given challenges with adherence to existing HIV prevention products, the development of an extended duration vaginal ring could improve adherence while reducing patient and provider burden.
Marie C D Stoner +11 more
doaj +2 more sources
High adherence to intermittent and continuous use of a contraceptive vaginal ring among women in a randomized controlled trial in Kigali, Rwanda [PDF]
BackgroundThe introduction of female-initiated drug-delivery methods, including vaginal rings, have proven to be a promising avenue to address sexually transmitted infections and unintended pregnancies, which disproportionally affects women and girls in ...
Evelyne Kestelyn +15 more
doaj +2 more sources
Acceptability of a dapivirine levonorgestrel vaginal ring in two Phase 1 trials (MTN-030/IPM 041 and MTN-044/IPM 053/CCN019): Implications for multipurpose prevention technology development. [PDF]
End-user feedback early in product development is important for optimizing multipurpose prevention technologies for HIV and pregnancy prevention. We evaluated the acceptability of the 90-day dapivirine levonorgestrel ring (DPV-LNG ring) used for 14 days ...
Barbara A Friedland +22 more
doaj +2 more sources
Phase 1 randomized pharmacokinetic and safety study of a 90‐day tenofovir vaginal ring in the United States [PDF]
Introduction Tenofovir‐based oral pre‐exposure prophylaxis is currently approved for HIV prevention; however, adherence in women has been low. A vaginal gel containing tenofovir (TFV) demonstrated partial protection to HIV but protection was not ...
Albert Y. Liu +16 more
doaj +2 more sources
Vaginal Ring Acceptability: A Systematic Review and Meta-Analysis of Vaginal Ring Experiences From Around the World [PDF]
Ariane van der Straten +2 more
exaly +2 more sources
Advances in contraception: vaginal contraceptive rings
The vaginal contraceptive ring is very effective and user dependent. In this article, we will discuss the different types of vaginal contraceptive rings, namely, the etonogestrel/ethinyl estradiol (ENG/EE) ring (NuvaRing, Merck, Rahway, NJ, USA) and the ...
Sara Al-Haddad +2 more
doaj +1 more source
Contraceptive rings promote vaginal lactobacilli in a high bacterial vaginosis prevalence population: A randomised, open-label longitudinal study in Rwandan women. [PDF]
BACKGROUND:Hormonal contraception has been associated with a reduced risk of vaginal dysbiosis, which in turn has been associated with reduced prevalence of sexually transmitted infections (STIs), including HIV.
Tania Crucitti +10 more
doaj +1 more source

